
Short Title: S1931 (PROBE Trial)
Enrollment Status: Recruiting
NCT #: NCT04510597
Specialty Area: Oncology
Condition Studied: Metastatic Renal Cell Carcinoma
Age Groups: Adult; Older Adult
Phase: III
This study is for people with kidney cancer (renal cell carcinoma) that has spread to other parts of the body. Everyone in the study receives a standard immunotherapy-based drug combination. The study looks at whether adding surgery to remove the kidney tumor after that treatment works differently than continuing the drug treatment alone.
Surgery to remove the primary kidney tumor when cancer has already spread is called a cytoreductive nephrectomy. Doctors do not yet agree on when, or whether, this surgery helps people who are also receiving modern immunotherapy-based treatment. This trial is designed to help answer that question.
Researchers hope to learn how the two approaches compare in terms of how long people live, how the cancer responds to treatment, side effects, and quality of life. The full technical description of the study is listed in the national clinical trials registry under identifier NCT04510597.
Taking part is voluntary. Your care team will explain the study in detail, answer your questions, and you may choose to stop participating at any time.
This study is enrolling adults with metastatic kidney cancer whose primary kidney tumor is still in place. The points below are a short summary of the main requirements, not the full eligibility list.
The study team reviews your medical history, test results, and imaging to confirm whether this trial is a fit for you. If you are interested, talk with your doctor or contact the study team listed for this trial.
If you join, you will first receive standard systemic therapy, then be placed by chance (randomly) into one of two groups. Your care team will walk you through each step before it happens.
How long you take part depends on how your cancer responds and how you are doing overall. The study team will explain the expected schedule, the possible risks and side effects, and any costs before you decide. You may leave the study at any time.
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT04510597
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.